The mission of the Division of Drug Delivery Technology is to provide new strategies for the delivery of biologically active compounds at the right dose, at the right time and at the right place. In order to achieve this, novel drug delivery systems are designed and the interactions of these delivery systems with biological systems are investigated at the (sub) cellular, tissue and organism level, both in vitro and in vivo. Currently the division focuses on three major research themes:

  • Transdermal and dermal drug delivery
  • Nasal and (epi) dermal vaccine delivery
  • Unwanted immunogenicity of therapeutic proteins


New insights for improved pertussis vaccines - Press release -

Researchers in Bilthoven, The Netherlands, have recently unraveled the defense against whooping cough bacteria in unprecedented detail. The outcome of the project, conducted at Intravacc (Institute for Translational Vaccinology) in Bilthoven, provides opportunities for a new approach in the development of improved whooping cough vaccines. The results have been published in PLoS ONE.

Read more
Third prize awarded to Pim Schipper for oral presentation at GPEN conference

Pim Schipper has won the third prize for his oral presentation during the tenth biennial meeting of the Globalization of Pharmaceutics Education Network (GPEN), which was held from 27 – 30 Aug 2014 at the University of Helsinki, Finland. The meeting was attended by about 260 participants: PhD students, postdocs and staff members from the participating universities as well as several scientists from industry.

Read more
Koen van der Maaden wins two poster awards

At the third International Conference on Microneedles,at the University of Maryland School of Pharmacy in Baltimore, 19-21 May 2014, Drs. Koen van der Maaden received an award for each of the two posters that he presented about work performed during his PhD project at DDT/LACDR.

Read more